We make innovative vaccines and specialty medicines to prevent and treat disease. Our R&D focuses on the science of the immune system, human genetics and advanced technologies.
Our R&D focus is on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.
Behind the science
Discover how we're getting ahead
Eosinophils could be holding the missing link between symptoms, diagnosis and treatment
Time for a change: personalising asthma treatment
Unlocking the power of the immune system to get ahead of hepatitis B
Tackling tomorrow’s health challenges today
How vaccine science can help tackle antimicrobial resistance
The 40 year fight against HIV
How the next generation of immuno-oncology could help us get ahead of cancer
1.4 million reasons to get ahead of gynaecologic cancers
Digital twin: using advanced technology to accelerate vaccine development
What if remission were the target of lupus care?
Life at GSK
How we help people thrive
Diversity, equity and inclusion
Positively impacting society and the planet
Pricing and access
We are making our products affordable and available to more people around the world through responsible pricing, strategic access programmes and partnerships.
Global health and health security
We are committed to using our science, our partnerships, and the knowledge we’ve gained from addressing the world’s biggest health challenges to improve health globally.
Diversity, equity and inclusion
Our work supports the health of all kinds of people. To meet our diverse patients' needs better, we need diversity in our clinical trials and to support our own people to thrive as part of an inclusive team.
We are working towards a net zero impact on climate and a net positive impact on nature by 2030, across our full value chain.
Ensuring the quality, safety and reliable supply of our products is critical to our purpose of uniting science, talent and technology to get ahead of disease together.
In the spotlight
GSK on social
Congratulations to the Inspirational Child 4-6 years winner, Henry. Always pushing the boundaries, Henry is defying all predictions and determined to show how well you can live with a tracheostomy.
Every year the #WellChildAwards honour the incredible children and young people from across the UK who live with serious illness. We’re so proud to have supported the Inspirational Child 4-6 years Award at the 2022 WellChild Awards.
We are excited to share the stories of the inspirational young people and extraordinary healthcare professionals from the 2022 #WellChildAwards. Available to view online from 1PM today gsk.to/3E2cUbFd4
Two years on from setting our goals for a #netzero impact on #climate and a net positive impact on #nature for a healthier planet, we’ve made good progress. We’re sharing our top 5 learnings to help others tackling these shared challenges. #GettingItDone
Our Chief Procurement Officer Lisa Martin at #ClimateWeekNYC discusses how our new sustainable procurement programme is helping to reach our climate and nature goals for a healthier planet. twitter.com/ClimateGroup/s…
GSK and @ViiVHC are committed to helping patients stay ahead of diseases like #HIV and #TB by finding new prevention and treatment options. As the @GlobalFund calls on the global community to #FightForWhatCounts we’re pleased to support the Global Fund Emergency Fund. twitter.com/GlobalFund/sta…
#News for #Investors and #Media Today we entered into an exclusive license agreement with Spero Therapeutics. This builds on our commitment to grow our late-stage pipeline of new medicines and vaccines to help get ahead of infectious diseases. gsk.com/en-gb/home/
Last month, we were a sponsor of the @Sole2SoulforMPN trek, raising awareness and funds for MPNs including myelofibrosis – a chronic #bloodcancer. Learn the team’s story, available now during #BloodCancerAwarenessMonth.
We're proud to be a founding partner of the Broadening Horizons Programme. It's important we support Black and minority ethnic students to further their studies and aligns to our commitment to develop diverse talent that reflects the communities we serve: gsk.to/3xBK0Ll
Join our Chief Procurement Officer Lisa Martin at 1:30pm EST when she’ll be talking about our new sustainable procurement programme during a #ClimateWeekNYC panel on supply chain emission reductions.